These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37287907)

  • 1. Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment.
    Zeng S; Zhang Z; Ye C; Wang J; Jing C; Li L
    Front Oncol; 2023; 13():1171926. PubMed ID: 37287907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
    Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
    Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Immunomodulatory Roles of Semaphorin 4D in Human Periapical Lesions.
    Zeng Y; Wang L; Liu L; Wang M; Yan L; Ye L; Song D; Huang D
    J Endod; 2023 Jan; 49(1):62-68. PubMed ID: 36257402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sema4D is required in both the adaptive and innate immune responses of contact hypersensitivity.
    Zhu Z; Luo Y; Yu J; Gao J; Zhang Y; Xiao C; Zhang C; Wang G; Liu Y; Fu M; Yao X; Li W
    Mol Immunol; 2016 Oct; 78():98-104. PubMed ID: 27614265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Wu G; Chen M; Ren H; Sha X; He M; Ren K; Qi J; Lin F
    Front Cell Dev Biol; 2022; 10():930933. PubMed ID: 35874816
    [No Abstract]   [Full Text] [Related]  

  • 8. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
    Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
    Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
    Lontos K; Adamik J; Tsagianni A; Galson DL; Chirgwin JM; Suvannasankha A
    Front Endocrinol (Lausanne); 2018; 9():322. PubMed ID: 29971044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Cancer Molecular Characterization of m
    Zhu J; Xiao J; Wang M; Hu D
    Front Oncol; 2020; 10():618374. PubMed ID: 33585244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis of
    Wang X; Tang Y; Liu R; Li W; Liu S; Zhou X
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-23. PubMed ID: 36989393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
    Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment.
    Ji H; Ren M; Liu T; Sun Y
    Dis Markers; 2021; 2021():5350232. PubMed ID: 34840630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
    Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y
    Front Immunol; 2022; 13():951247. PubMed ID: 35935945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological role and prognostic potential of CLEC10A in pan-cancer.
    Qin Y; Wang L; Zhang L; Li J; Liao L; Huang L; Li W; Yang J
    Am J Transl Res; 2022; 14(5):2844-2860. PubMed ID: 35702069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
    Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
    Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.